Roche's Elecsys® pTau181 becomes the only FDA-cleared blood test for use in primary care to rule out Alzheimer's-related amyloid pathology [Yahoo! Finance]
Lindsay Corporation (LNN)
Last lindsay corporation earnings: 4/7 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
lindsayir.com
Company Research
Source: Yahoo! Finance
Provides new opportunity to broaden access and improve referral quality Features as part of Roche's growing portfolio designed to further shape Alzheimer's diagnostic pathways INDIANAPOLIS Oct. 13, 2025 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the United States Food and Drug Administration (FDA) has cleared its Elecsys pTau181 test, the only blood-based biomarker (BBM) test indicated as an aid in the initial assessment for Alzheimer's disease and other causes of cognitive decline in the primary-care setting. The Elecsys pTau181 test is intended for patients ages 55 and older presenting with signs, symptoms or complaints of cognitive decline. It measures phosphorylated Tau (pTau) 181 protein in human plasma, a key biomarker for Alzheimer's pathology, including amyloid plaque and tau aggregate pathology. Roche Logo (PRNewsfoto/Roche) Developed in collaboration with Eli Lilly and Company, this minimally invasive test provides clinicians with inform
Show less
Read more
Impact Snapshot
Event Time:
LNN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LNN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LNN alerts
High impacting Lindsay Corporation news events
Weekly update
A roundup of the hottest topics
LNN
News
- Lindsay Corporation Announces New $150 Million Share Repurchase ProgramBusiness Wire
- Lindsay Corporation Announces Quarterly Cash DividendBusiness Wire
- Lindsay (NYSE:LNN) was given a new $122.00 price target on by analysts at Stifel Nicolaus.MarketBeat
- Lindsay Corporation Reports Fourth Quarter and Fiscal Year 2025 ResultsBusiness Wire
- Sam Hinrichsen Joins Lindsay as Senior Vice President and Chief Financial Officer [Yahoo! Finance]Yahoo! Finance
LNN
Earnings
- 10/23/25 - Miss
LNN
Sec Filings
- 12/3/25 - Form 4
- 12/3/25 - Form 3
- 11/21/25 - Form ARS
- LNN's page on the SEC website